A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Risk of Iron Deficiency and Anaemia in African Children

NCT ID: NCT07186205

Last Updated: 2026-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

126 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-13

Study Completion Date

2026-01-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An exploratory study to collect data to build artificial intelligence derived algorithms for estimating iron status in African children

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an exploratory, observational, pilot study that aims to build and measure the accuracy of an algorithm that estimates a child's iron status using images and/or videos, against standard venous blood sampling. Images and/or videos will be collected by healthcare professionals, together with blood test results. This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements. Data on the acceptance and experience of the using the algorithm will be collected for improvements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Deficiencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children aged 6-72 months of age

Approximately 120 children aged above 6 months old and below 6 years of age across potential study sites. Subjects will be grouped by haemoglobin (Hb) level ranging from \<6 g/dL to ≥ 14.0 g/dL.

Standard blood test

Intervention Type DIAGNOSTIC_TEST

Blood test will measure haemoglobin and other parameters

Imaging and videography of anatomical sites

Intervention Type OTHER

Images and videos of anatomical sites will be collected to develop algorithms to estimate iron status

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard blood test

Blood test will measure haemoglobin and other parameters

Intervention Type DIAGNOSTIC_TEST

Imaging and videography of anatomical sites

Images and videos of anatomical sites will be collected to develop algorithms to estimate iron status

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children over 6 months of age and under 6 years of age.
* Written consent from the legally acceptable parent(s) or representative(s), who are themselves ≥ 18 years of age, to consent to and comply with the terms and conditions of the study.
* The parent(s) must be able to understand the content of the study and complete the study questionnaires.
* Parents should be comfortable with their child having blood drawn.
* The participant must have a haemoglobin level corresponding to a haemoglobin group with open slots for participation.

Exclusion Criteria

* Children with a medical condition that, in the opinion of the investigator, would render them unsuitable for enrolment
* Children with nail bed obstructions, nail polish, nail discoloration (e.g., leukonychia, melanonychia, bruising, etc.), or scarring of the lips, or lip pigmentation due to thyroid dysfunction (e.g., Peutz-Jeghers syndrome)
* Children who are unable to cooperate with study procedures
* Employees and/or children/family members or parents of employees of the Danone Global Research \& Innovation Center or Danone affiliates participating sites
* Children whose health condition requires emergency care
Minimum Eligible Age

6 Months

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de Sante Publique

OTHER

Sponsor Role collaborator

Hospital Center Régional D'abobo Félix Houphouët Boigny

UNKNOWN

Sponsor Role collaborator

Hôpital Mère Enfant Bingerville

UNKNOWN

Sponsor Role collaborator

Danone Asia Pacific Holdings Pte, Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amed Coulibaly, MBBS

Role: PRINCIPAL_INVESTIGATOR

Institut National de Santé Publique (INSP)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Center Régional D'abobo Félix Houphouët Boigny

Abidjan, , Côte d’Ivoire

Site Status

Institut National de Sante Publique

Abidjan, , Côte d’Ivoire

Site Status

Hôpital Mère Enfant Bingerville

Bingerville, , Côte d’Ivoire

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Côte d’Ivoire

References

Explore related publications, articles, or registry entries linked to this study.

Tounian P, Chouraqui JP. [Iron in nutrition]. Arch Pediatr. 2017 May;24(5S):5S23-5S31. doi: 10.1016/S0929-693X(17)24006-8. French.

Reference Type BACKGROUND
PMID: 28622779 (View on PubMed)

da Silva Lopes K, Yamaji N, Rahman MO, Suto M, Takemoto Y, Garcia-Casal MN, Ota E. Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews. Cochrane Database Syst Rev. 2021 Sep 26;9(9):CD013092. doi: 10.1002/14651858.CD013092.pub2.

Reference Type BACKGROUND
PMID: 34564844 (View on PubMed)

Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016 Feb 27;387(10021):907-16. doi: 10.1016/S0140-6736(15)60865-0. Epub 2015 Aug 24.

Reference Type BACKGROUND
PMID: 26314490 (View on PubMed)

Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015 May 7;372(19):1832-43. doi: 10.1056/NEJMra1401038. No abstract available.

Reference Type BACKGROUND
PMID: 25946282 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24REX0083183

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Baby Iron Bioavailability Study
NCT03754543 COMPLETED NA